Skip to Content
About Us Become an Authorised Buyer Medical Partners Blog Contact Us
🌐Ship toSelect country
  1. All products
  2. Fillers
  3. Brands
  4. STYLAGE®
  5. Stylage Bi-Soft XXL - 2 x 1,0ml
  6. STYLAGE®
Pricelist: Default Pricelist
Pricelist: Default Pricelist
Stylage Bi-Soft XXL - 2 x 1,0ml

Stylage Bi-Soft XXL - 2 x 1,0ml

Stylage Bi-Soft XXL is the highest-viscosity, most volumising product in Laboratoires Vivacy's Stylage range, built on IPN-Like technology with mannitol. Its high elasticity and viscosity make it well suited to accentuating cheekbones, improving chin shape, restoring volume to sunken temples and redefining the facial oval, with reported results lasting up to 18 months. For use by licensed, trained medical professionals only.

Contouring
154.00 € 154.00 €
  • Brand
Contact Us
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand STYLAGE®
SKU A5212 Share
Treatment Areas CheeksChinJawline
Tags Contouring

Stylage Bi-Soft XXL is the highest-viscosity formulation in Laboratoires Vivacy's Stylage range, built on IPN-Like technology with mannitol, designed for the deepest volumising needs and significant facial contouring.

CONCENTRATION

  • Cross-linked hyaluronic acid (IPN-Like technology, highest viscosity) + mannitol

THE PACK INCLUDES

  • 2 x 1.0ml Syringes

STORAGE CONDITIONS

  • Store between 2°C and 25°C
  • Do not freeze

RESULTS & DURATION

Results typically last 12-18 months, depending on individual metabolism.

INDICATIONS

  • Significant loss of facial volume
  • Deep facial contouring

TREATMENT AREAS

  • Cheeks
  • Chin
  • Face, general

Stylage Bi-Soft XXL is injected into the deep dermis or subcutaneous plane using bolus technique.

Results are visible immediately, with final results assessed after 2-4 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin